0001654954-22-013450.txt : 20221006 0001654954-22-013450.hdr.sgml : 20221006 20221006162507 ACCESSION NUMBER: 0001654954-22-013450 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221006 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221006 DATE AS OF CHANGE: 20221006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS CENTRAL INDEX KEY: 0001040470 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942424084 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22893 FILM NUMBER: 221298423 BUSINESS ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 5106239400 MAIL ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 8-K 1 aehr_8k.htm FORM 8-K aehr_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

_________________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

October 6, 2022

 

_________________________

 

AEHR TEST SYSTEMS

(Exact name of registrant as specified in its charter)

  

California

 

000-22893

 

94-2424084

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

400 KATO TERRACE

FREMONT, CA 94539

(Address of principal executive offices, including zip code)

 

510-623-9400

(Registrant’s telephone number, including area code)

 

 N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

AEHR

The NASDAQ Capital Market

 

 

 

 

Item 2.02.  Results of Operations and Financial Condition.

 

On October 6, 2022, Aehr Test Systems, or the Company, issued a press release announcing the Company’s financial results for its first quarter of fiscal year 2023 ended August 31, 2022.  A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Form 8-K, including the exhibit attached hereto, are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)  Exhibits.

  

Exhibit No.

 

 Description

 

 

 

99.1

 

Press Release of Aehr Test Systems dated October 6, 2022 entitled “Aehr Test Systems Reports 89% Revenue Growth Year over Year in First Quarter of Fiscal 2023 on Strength of Wafer Level Test and Burn in of Silicon Carbide Devices used in Electric Vehicles.”

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Aehr Test Systems

(Registrant)

 

 

 

 

Date: October 6, 2022

By:

/s/ Kenneth B. Spink

 

 

 

Kenneth B. Spink

Vice President of Finance and

Chief Financial Officer

 

 

 
3

 

 EX-99.1 2 aehr_ex991.htm PRESS RELEASE aehr_ex991.htm

 

EXHIBIT 99.1

 

 

FOR IMMEDIATE RELEASE

 

Contacts:

 

 

 

Aehr Test Systems

MKR Investor Relations Inc.

Ken Spink

Todd Kehrli or Jim Byers

Chief Financial Officer

Analyst/Investor Contact

(510) 623-9400 x309

(213) 277-5550

 

aehr@mkr-group.com

  

Aehr Test Systems Reports 89% Revenue Growth Year over Year in First Quarter of Fiscal 2023 on Strength of Wafer Level Test and Burn in of Silicon Carbide Devices used in Electric Vehicles

 

Fremont, CA (October 6, 2022) – Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial results for its first quarter of fiscal 2023 ended August 31, 2022.

 

Fiscal First Quarter Financial Results:

 

 

·

 Net sales were $10.7 million, up 89% from $5.6 million in the first quarter of fiscal 2022.

 

·

 GAAP net income was $589,000, or $0.02 per diluted share, compared to GAAP net income of $696,000, or $0.03 per diluted share, in the first quarter of fiscal 2022, which includes the impact of forgiveness of $1.7 million in loans from the Paycheck Protection Program (“PPP”).

 

·

 Non-GAAP net income was $1.3 million, or $0.05 per diluted share, which excludes the impact of stock-based compensation, compared to a non-GAAP net loss of $414,000, or $0.02 per diluted share, in the first quarter of fiscal 2022, which excludes the impact of stock-based compensation and forgiveness of the PPP loan.

 

·

 Bookings were $19.1 million for the quarter ended August 31, 2022.

 

·

 Backlog as of August 31, 2022 was $19.5 million.

 

·

 Total cash and cash equivalents as of August 31, 2022 were $36.1 million, up from $6.5 million at the end of the first quarter of fiscal 2022.

 

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

 

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

 

“We are off to a good start this year, finishing the first quarter with revenue and net income ahead of consensus estimates, and with strong bookings of $19.1 million.

 

“We are currently engaged or in discussions with almost all the existing and future silicon carbide suppliers regarding our unique, low cost, multi-wafer level test and burn-in solution that provides test electronics and device contactor technology that enables contact to 100% of devices on a single wafer. This allows our customers to burn-in every device at a lower cost than they could in any other form due to our ability to contact thousands of devices on a single wafer and test 18 wafers in a single system at one time with our FOX-XPTM multi-wafer test and burn-in system and proprietary FOX full wafer contact WaferPaksTM. The major silicon carbide companies expect that most electric vehicle traction inverters will move to multi-chip modules, and they have told us that they must move to wafer-level stress and burn-in to remove the inherent failures before they put these devices into multi-die modules to meet their cost, yield, and reliability goals of these modules. Aehr’s technology provides a total turnkey single vendor solution to meet these customers’ critical test and stress requirements.

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 2 of 7

  

“Our lead customer for silicon carbide wafer level burn-in continues to ramp up use of our FOX-XP multi-wafer test and burn-in systems and WaferPaks, placing another significant order with us during this quarter. Similar to past orders, they purchased the systems without the necessary WaferPak full wafer contactors and as such we expect significant orders from them for WaferPaks to match these systems. This need for additional capacity is being driven by increased demand for silicon carbide semiconductors for electric vehicles. This customer recently announced that they expect their growth rate to accelerate faster than previously forecasted, and they continue to forecast orders for a significant number of FOX systems and WaferPak Contactors over the next several years.

 

“Our previously announced benchmarks and evaluations with two additional major silicon carbide semiconductor suppliers continued to move forward with great progress during the quarter. Following the end of the quarter, we announced an initial purchase order from one of these suppliers for our FOX-NP multi-wafer test and burn-in system, multiple WaferPak Contactors, and a FOX WaferPak Aligner to be used for qualification of our wafer level burn-in solution for silicon carbide devices for electric vehicles and other markets. This new customer is one of the world’s largest suppliers of silicon carbide devices serving several significant markets including the electric vehicle industry. We have already shipped the system to them, and we believe we will achieve their specific performance and functionality evaluation criteria on their test floor during the next three to six months as well as expect that they will be purchasing our FOX-XP production systems for shipment before the end of this fiscal year ending May 31, 2023. The benchmark with the other potential customer has also progressed significantly since last quarter’s conference call. We completed a significant milestone with a large number of wafers being tested, and we believe that we will successfully complete their correlation over the next few months, allowing them to also move forward with our FOX solution. We expect both of these major silicon carbide suppliers to implement our FOX platform solution into their volume manufacturing production flow as they look to capitalize on the fast-growing demand for silicon carbide devices in electric vehicles.

 

“We see demand building for wafer level burn-in of silicon carbide devices and specifically for traction inverters and onboard and offboard chargers for electric vehicles. During the last few months, multiple additional silicon carbide suppliers have asked us to provide technical feasibility, quotations, and schedules for production test and burn-in of their wafers. While some of these companies want to do on-wafer validation of our solutions before they place orders for systems from us, others are planning to move directly to purchasing our FOX systems and WaferPaks to accelerate their time to market. The silicon carbide market for electric vehicles and its supporting infrastructure requirements are growing at a tremendous rate, with Canaccord Genuity estimating that wafer capacity will increase from 125,000 6-inch wafers in 2021 to over four million 6-inch equivalent wafers in 2030 to meet the electric vehicle market alone.

 

“In addition to our progress with silicon carbide applications, we are seeing an increase in our wafer level burn-in business for silicon photonics devices used in data communications. We shipped multiple FOX-NP systems this quarter to support the characterization and product qualification of new photonics-based devices. We have also received multiple orders for upgrades to existing systems that enable a higher number of devices and higher power per wafer, as well as for new designs for WaferPaks that we expect will first be ordered for engineering and new product introduction, and then turn to volume production with higher quantity orders. 

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 3 of 7

  

“We are very encouraged by the continued positive momentum and expanding growth opportunities we are seeing with current and prospective customers and are reiterating our previously announced guidance for revenue this fiscal year as we expect revenue to grow over the next three quarters. We believe that we will receive production orders from several silicon carbide customers beyond our lead customer and begin shipping systems to meet their production capacity by the end of our current fiscal year that ends May 31, 2023. Beyond our engagements with some of the top major automotive suppliers, we are also seeing high levels of interest and discussion with other silicon carbide prospects across the spectrum of industrial, solar, wind, and charging infrastructure markets that is expanding our potential customer base and giving us increased confidence about our growth prospects for fiscal 2024 and beyond.”

 

Fiscal 2023 Financial Guidance:

 

For the fiscal year ending May 31, 2023, Aehr is reiterating its previously provided guidance for total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.

 

Management Conference Call and Webcast

 

Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its first quarter fiscal 2023 operating results. To access the live call, dial +1 877-270-2148 (US and Canada) or +1 412-902-6510 (International) and ask to join the Aehr Test Systems earnings call. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and may also be accessed by clicking here. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call and will remain available for one week. To access the call replay, dial +1 877-344-7529 (US and Canada) or +1 412-317-0088 (International) and enter replay passcode 8724719.

 

About Aehr Test Systems

 

Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in semiconductor devices in wafer level, singulated die, and package part form, and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge silicon carbide-based power semiconductors, memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 4 of 7

   

Safe Harbor Statement

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “going to,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “sees,” or “continue,” or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future, including the second quarter of fiscal 2023; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPakTM and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2023, including related to revenue and profitability, and expectations regarding fiscal 2023; Aehr’s ability to expand its number of customers using its FOX-PTM solutions; the ability to secure potential customer engagements; expectations related to long-term demand for Aehr’s productions and the attractiveness of key markets; the belief that Aehr will be stronger after the current worldwide COVID-19 pandemic, including expectations related to greater production, more customers, more applications, and higher value products. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

  

–  Financial Tables to Follow  –

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 5 of 7

  

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

Aug 31,

 

 

May 31,

 

 

Aug 31,

 

 

 

2022

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 $ 10,671

 

 

 $ 20,289

 

 

 $ 5,646

 

Cost of sales

 

 

 6,190

 

 

 

 9,821

 

 

 

 3,365

 

Gross profit

 

 

 4,481

 

 

 

 10,468

 

 

 

 2,281

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

 2,525

 

 

 

 2,993

 

 

 

 1,953

 

Research and development

 

 

 1,498

 

 

 

 1,655

 

 

 

 1,321

 

Total operating expenses

 

 

 4,023

 

 

 

 4,648

 

 

 

 3,274

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

 458

 

 

 

 5,820

 

 

 

 (993 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income (expense), net

 

 

 121

 

 

 

 22

 

 

 

 (9 )

Gain from forgiveness of PPP loan

 

 

 -

 

 

 

 -

 

 

 

 1,698

 

Other income (expense), net

 

 

 24

 

 

 

 (38 )

 

 

 23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income tax expense

 

 

 603

 

 

 

 5,804

 

 

 

 719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

 (14 )

 

 

 (10 )

 

 

 (23 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 $ 589

 

 

 $ 5,794

 

 

 $ 696

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $ 0.02

 

 

 $ 0.21

 

 

 $ 0.03

 

Diluted

 

 $ 0.02

 

 

 $ 0.20

 

 

 $ 0.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 27,242

 

 

 

 27,003

 

 

 

 23,999

 

Diluted

 

 

 28,788

 

 

 

 28,568

 

 

 

 25,356

 

 

- more-

 

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 6 of 7

  

AEHR TEST SYSTEMS AND SUBSIDIARIES

Reconciliation of GAAP to Non-GAAP Results

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

Aug 31,

 

 

May 31,

 

 

Aug 31,

 

 

 

2022

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

GAAP net income

 

 $ 589

 

 

 $ 5,794

 

 

 $ 696

 

Stock-based compensation expense

 

 

 710

 

 

 

 737

 

 

 

 588

 

Gain from forgiveness of PPP loan

 

 

 -

 

 

 

 -

 

 

 

 (1,698 )

Non-GAAP net income (loss)

 

 $ 1,299

 

 

 $ 6,531

 

 

 $ (414 )

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income per diluted share

 

 $ 0.02

 

 

 $ 0.20

 

 

 $ 0.03

 

Non-GAAP net income (loss) per diluted share

 

 $ 0.05

 

 

 $ 0.23

 

 

 $ (0.02 )

Shares used in GAAP diluted shares calculation

 

 

 28,788

 

 

 

 28,568

 

 

 

 25,356

 

Shares used in non-GAAP diluted shares calculation

 

 

 28,788

 

 

 

 28,568

 

 

 

 23,999

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income (loss)  is a non-GAAP measure and should not be considered a replacement for GAAP results.  Non-GAAP net income (loss)  is a financial measure the Company uses to evaluate the underlying results and operating performance of the business.  The limitation of this measure is that it excludes items that impact the Company's current period net income.  This limitation is best addressed by using this measure in combination with net income (loss)  (the most directly comparable GAAP financial measure).  These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. 

 

We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. 

 

-more-

 

 

 

 

Aehr Test Systems Reports First Quarter Fiscal 2023 Financial Results

October 6, 2022

Page 7 of 7

  

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

 

 

 

 

 

 

 

August 31,

 

 

May 31,

 

 

 

2022

 

 

2022

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

 $ 36,147

 

 

 $ 31,484

 

Accounts receivable, net

 

 

 5,116

 

 

 

 12,859

 

Inventories

 

 

 17,233

 

 

 

 15,051

 

Prepaid expenses and other

 

 

 833

 

 

 

 613

 

Total current assets

 

 

 59,329

 

 

 

 60,007

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

 1,322

 

 

 

 1,203

 

Operating lease right-of-use assets

 

 

 740

 

 

 

 917

 

Other assets

 

 

 187

 

 

 

 201

 

Total assets

 

 $ 61,578

 

 

 $ 62,328

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

 

 3,387

 

 

 

 4,195

 

Accrued expenses

 

 

 2,479

 

 

 

 3,610

 

Operating lease liabilities, short-term

 

 

 741

 

 

 

 794

 

Customer deposits and deferred revenue, short-term

 

 

 3,292

 

 

 

 2,415

 

Total current liabilities

 

 

 9,899

 

 

 

 11,014

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, long-term

 

 

 73

 

 

 

 212

 

Deferred revenue, long-term

 

 

 47

 

 

 

 69

 

Other liabilities

 

 

 41

 

 

 

 44

 

Total liabilities

 

 

 10,060

 

 

 

 11,339

 

 

 

 

 

 

 

 

 

 

Total shareholders' equity

 

 

 51,518

 

 

 

 50,989

 

 

 

 

 

 

 

 

 

 

Total liabilities and shareholders' equity

 

 $ 61,578

 

 

 $ 62,328

 

 

# # #

 

 

 EX-101.SCH 3 aehr-20221006.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 aehr-20221006_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Entity File Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 aehr-20221006_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 aehr-20221006_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 aehr-20221006_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 aehr_ex991img9.jpg begin 644 aehr_ex991img9.jpg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�!\3_P!I7_\ MS_7'_?UO\:_6GP/G_A7'AEB22=+M22>2?W*U^1=>X:?^U#\7M+TJTTNSUBR6 MVM(4@B4V$1(15"@9QSP* /THKY8_;2FF@^'7AEH)GB)U1@2C%<_NF]*\&_X: MT^-7_0;L?_!?%_A7(^/OC/X]^)FDVNE^+-0M[FVM)OM$2Q6J1$/M*]5'/!- M$OP>O+J;X@SK)=3N/[%U4X,C=?L$_O7G?]I7_P#S_7'_ '];_&N\^#'_ "42 M?_L":M_Z03UYQ0!W*^!OBI(BR1^$?%3H0&5EL+D@@]"/EIG_ @GQ7_Z$WQ9 M_P""^Y_^)K[YTG]HKX+V^A6%O/X[MEEBMXT=3;3\$* ?^6=7?^&DO@E_T/EM M_P" UQ_\;H _-]K[Q)H.J-&U[J6F:A;-AE,DD,L3=>>00:^__P!F+X@ZY\0/ MA5<-XBNGO]2TF\-H;J3EYH]BLA<]V&2,]\ GG)KY _: \9:#XZ^,NI:_X9G^ MTZ:T4,*W!C,?GLB %L, <=AD=!7TQ^QCIMY;?"C7=2FA:.&]U/$#-P) D:@D M>V21GU!]* +FO^%?$C^)=4DCT>X>-[J1E8=&4L2"*S?^$1\3_P#0#N/R'^-: MGB&;Q8/%&IA'U<1BZD"",R[-NXXQCC%9?G^,/^>FL_G+7Y_6IT?:2O&6[[?Y M'ZWA,3BE0ARSALN_;U%_X1+Q-_T [G_OD?XT?\(EXF_Z =S_ -\C_&CSO&'] M_6OSEH\[QA_?UK\Y:P]E0_EE^'^1V?6<9_S\A^/^8?\ ")>)O^@'<_\ ?(_Q MH_X1+Q-_T [G_OD?XT>=XP_OZU^,/[^M?G+1[*A_++\/\@^LXS_ )^0 M_'_,/^$2\3?] .Y_[Y'^-'_")>)O^@'<_P#?(_QH\[QA_?UK\Y:/.\8?W]:_ M.6CV5#^67X?Y!]9QG_/R'X_YA_PB7B;_ * =S_WR/\:/^$2\3?\ 0#N?^^1_ MC1YWC#^_K7YRT>=XP_OZU^QP_\LOP_P @^LXS_GY#\?\ ,L?M<_$S_A'O M!D/@'3+K;J6O+ONRIYBM <$?\#88^BN.]?"$,$T[%8(7E8#)"*6('X5]A_$/ M]GGQ!\0O'^K>+-2^)WAY9+R8^5%N8B"(<1QCGLH ]SD]Z]4^!'PKT'X1Z-JT MEWXDTS5=6OY%\Z[@D54BA7[B#)R/F+$GOQZ5^D'XP?'<'QL^-]K;16UOXLU6 M*&)1''&EN@"J!@ #9T K!\6>._B3XXLK>S\6:IJ&K06TAEA6> ?(Q&"00H/2 MOU*_M[0_^@U8_P#@0G^-+)JFF6\<H)/- 'Y*^$_$FI> M#_%^E^)])D\N]TZ=9X_1L=5/LPRI]B:^Y?V@/%&F^,_V/V\4:/)OLM2>SF0$ MY*'S5#(?=6!4^X-<1XT_92A\4>/=;UWPCXTT>PTNZE-W]D8%S;%N7Y4X"[MQ M'3 (':M?3/@AK5M\$O$'PQO/B1X>N+.^NX+VRD#'_1G5P9 >?NL%7 '0Y]: M/DWX;WWAG3?B5HE]XRMDN?#\,Y:\B>'S59-IX*=^<5]6?\+&_8Y_Z%.Q_P#! M(W^%<9:_L9ZY>[C9_$30[D+]XPQN^WZX-+<_L8Z]9()+SXA:+;(3@-+$Z G\ M30!V7_"QOV.?^A3L?_!(W^%;.B_$;]GVZM->T/X;:5#IVN:KI%Y"I@TQH/,5 M+=Y"K-C&,(3^%>70_L=ZM7;_$C0)GP6VQJS' ZG@UUGP[_9#M$U2\T"Z>Y MN["">5A?S*"[1JQ. W')->.?\,:ZT+[["?B)H0NO^>&Q]_3/W.E 'F?\ PR=\$_\ H7KS_P &,W_Q M5>#_ +3/P;\ _#7P7HNI>$=,GM+F[OS!*TEU)*"GELV,,3CD"OMR;5--MUC: MXU&VA$B[D+S*N\>HR>17C?QX\ VOQ@\,:3I&F>,-(TU[&[-RSW$H<."A7 VG MWH ^(O@Q_P E$G_[ FK?^D$]><5]D^"_V9[KPCXIEU.Z^(F@3 V-[9&)20P: M:VDA!Y/8N"?H:YE?V/\ 4FC>1?B9X?*)CWQNEFLP=BCRU7;SW^6@#C]?\ &7B:'Q-J<*:Q M(BQ74B*HC7"J&( Z5G?\)QXH_P"@W+_W[3_"M[7?'VOP>)-2MT^R;(KAXTW0 M9. Q R<\FL[_ (6)XBQ_RX_^ _\ ]>O@:TX^TE^\EN^G_!/U;"T9NC!_5X/1 M=5V]"E_PG'BC_H.2_P#?M/\ "E_X3CQ1_P!!R3_OVG^%7?\ A8GB+_IR_P# M'WK_(I?\)QXH_Z#DG_ M '[3_"C_ (3CQ1_T')/^_:?X5=_X6)XC];+_ ,!__KT?\+$\1^ME_P" _P#] M>GS1_P"?LON?^8>QG_T#P^]?Y%+_ (3CQ1_T')/^_:?X4?\ "<>*/^@Y)_W[ M3_"KO_"Q/$?K9?\ @/\ _7H_X6)XC];+_P !_P#Z]'-'_G[+[G_F'L9_] \/ MO7^12_X3CQ1_T')/^_:?X4?\)QXH_P"@Y)_W[3_"KO\ PL3Q'ZV7_@/_ /7H M_P"%B>(_6R_\!_\ Z]'-'_G[+[G_ )A[&?\ T#P^]?Y%'_A./%'_ $')?^_: M?X45>_X6)XB_Z63C#$XY KK?CG\'_ ?PU^ ^MZEX1TN:SN; MZ:TAF:2ZDERGFAL88G'([5U_[5D$%QX&\,_:(4F_XF9^^H;_ )9MZUO_ +34 M:2?L_7BR(KC[3;<,,_QBOT0_'CYJTWP9HLVB6$S_ Y\#3R/;QL99O&CQ.Y* M@[F3SQM)ZD=CQ6KXV\%1ZA\7;"/3=-\-^*[&UT&SAB\./XB-N+)5@C&%D,B% MU!.X$,=P?)YKR3^S--_Z!]M_WZ7_ KJ?C[96=KIOP]FMK2&"63PUI^]XXPI M;]P.I'6@#J?#V@Z+H/QT\+Z/KWPZ;PM_;2R:>(M(\1+>13+*K1-Y@)D;!#X( MWKZ@<5;^./P<\ ^"_B7\-]$\.Z7-;66NWQAOD>ZDD,B>="N 6)*\.W(]?:N( M_9Y^/FD?:+>.;RU:1/,4-L;8?F&>A]Z^D?VAX89/B]\(C)"CD:D?O*#_ M ,MH* /6?A_\+?!OPSAOXO!^G2V2:@R-<"2X>7<4W!?O$X^\>E?/_P"TCX?D M\0?&GPHHET?6_)L=K>&[_5/L+39>0[PQ90 P'4-G,>/2OKNOC;]M"UMO+T*] M^SQ?:O+:/SM@W[=Y^7=UQ[4 !\K$#YQ^"EK;7?QS\,6UU;Q7$!OXLQRH&4_,.QXK[9_:HABD^" M#B2)'']H0<,H/9J /._#OPEFTOX%>+/B%XOUZW3QIXHTUYCJMY+B.QCF PN\ M [2X8!F X#!1P#GRKP_\/9?^$)MYI/A#X<\2CRF)UB'Q<(7F&3\X3SPJD=,; M>W2OLF:UM;KX(2V5U;13VI\.)^YD0,G_ ![_ -T\5^6,_P#Q\R_[Q_G0!]K? M!+X:_#'XM_"2SEUK1=3D.AWEQ9QQW.I,WE[@DA"-&$^7Y@<$9!+5R/[-?P;\ M _$;0/$EYXLTJ:\FL-0$$!2ZDB"IMSC"D9Y]:]]_9HM;6V^ ^@FVMHH3.[22 MF- OF-@?,V.I]S7._LL00V_A7Q7]GA2'_B9+_JU"_P 'M0!\VZ7X?T_5OBC\ M0([GPQX>UM;;6)E0:UKS:9Y0,TOW,2)YF<<]<8'K6WXR\/Z5H_P-\3R6GAGP M[H=Q)?Z>N-'U]M4,J S9W@R/Y8!Q@\9R?2N8\?Z=I_\ PL_Q3_H-O_R%KK_E MDO\ SV;VJYH>FZ?_ ,*T\8_Z!;_>LO\ EDO_ #T;VH [W2?$,W[,WBW5(E@G MG\,^*M!34M*1\N%O!&"J,?0.S*W?:R$UQUKX'NO#'BCX-^*]>N)AK_BO6&U. M\EFY,2>? T3$?WL.TA[_ # =J]_^.^G:?=?#7X;?:K"WGQ>6T8\R)6PK0_,O M(Z' R.^*N_'"VMV^,/PAW6\;;-1^7*#Y?WT'3TH ^=?!_P /[JZ74KB3P3X: M^)9-XY_M8^*C:D\ D;?.0G.=V67/S5[-^RU.6:Q_ MM);VUB 9QB-@O4;L9W-D <\5\D?$NUMK/XF:Y;6=O%;P1W$@2.) BK\QZ <" MOK+]BZUMAX+\2W8MXA<-<0HTNP;ROS\$]<>U T=+KWBJWC\2ZFC>&-)D*7#J M7:$EFPQ&YCGJ:S?^$NAQ_P BKH__ 'Y_^O5GQ!!"?%&K9A0_Z1)U4?WS67]G MM_E_<1_]\BOSZK6K*I)C?]^3_C5;[-;_\ /O'_ -\"C[-;_P#/ MO'_WP*/;5OYOP0?4,+_)^++/_"70?]"GHW_?D_XT?\)=!_T*>C?]^3_C5;[- M;_\ /O'_ -\"C[-;_P#/O'_WP*/;5OYOP0?4,+_)^++/_"70?]"GHW_?D_XT M?\)=!_T*>C?]^3_C5;[-;_\ /O'_ -\"C[-;_P#/O'_WP*/;5OYOP0?4,+_) K^++/_"70?]"GHW_?H_XT56^S6_\ S[Q_]\"BCVU;^;\$'U#"_P OXL__V0$! end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
Oct. 06, 2022
Cover [Abstract]  
Entity Registrant Name AEHR TEST SYSTEMS
Entity Central Index Key 0001040470
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Oct. 06, 2022
Entity Incorporation State Country Code CA
Entity File Number 000-22893
Entity Tax Identification Number 94-2424084
Entity Address Address Line 1 400 KATO TERRACE
Entity Address City Or Town FREMONT
Entity Address State Or Province CA
Entity Address Postal Zip Code 94539
City Area Code 510
Local Phone Number 623-9400
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.01 per share
Trading Symbol AEHR
Security Exchange Name NASDAQ
XML 10 aehr_8k_htm.xml IDEA: XBRL DOCUMENT 0001040470 2022-10-06 2022-10-06 iso4217:USD shares iso4217:USD shares 0001040470 false 8-K 2022-10-06 AEHR TEST SYSTEMS CA 000-22893 94-2424084 400 KATO TERRACE FREMONT CA 94539 510 623-9400 false false false false false Common Stock, par value $0.01 per share AEHR NASDAQ EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://aehr.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aehr_8k.htm aehr-20221006.xsd aehr-20221006_cal.xml aehr-20221006_def.xml aehr-20221006_lab.xml aehr-20221006_pre.xml aehr_ex991.htm http://xbrl.sec.gov/dei/2022 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "aehr_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "aehr-20221006_cal.xml" ] }, "definitionLink": { "local": [ "aehr-20221006_def.xml" ] }, "inline": { "local": [ "aehr_8k.htm" ] }, "labelLink": { "local": [ "aehr-20221006_lab.xml" ] }, "presentationLink": { "local": [ "aehr-20221006_pre.xml" ] }, "schema": { "local": [ "aehr-20221006.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "aehr", "nsuri": "http://aehr.com/20221006", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "aehr_8k.htm", "contextRef": "From2022-10-06to2022-10-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://aehr.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "aehr_8k.htm", "contextRef": "From2022-10-06to2022-10-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aehr.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001654954-22-013450-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-013450-xbrl.zip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�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�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end